Zynex, Inc. (NASDAQ:ZYXI) just released its latest full-year report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

Zynex Inc. ZYXI recently announced the Food and Drug Administration (“FDA”) clearance of its new TensWave device, which aligns perfectly with Zynex’s commitment to providing comprehensive pain ...

Zynex, Inc. focuses on non-opioid pain management and patient monitoring, with a recent FDA approval and a promising product pipeline. Analyst firms remain positive on the company's prospects, and ...

Zynex (NASDAQ:ZYXI) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Zynex to report an earnings ...

LITTLETON, Colo.--(BUSINESS WIRE)-- Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces plans to ...

Products sold in the past by Zynex for pain management have failed to penetrate the market. Zynex's new products are radically different from their predecessors: more specific and innovative. The new ...

NEW YORK, May 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period ...

* Depreciation does not include amounts related to units on lease to third parties which are depreciated and included in cost of goods sold. ** Severance of former corporate employees which were fully ...

Zynex (NASDAQ:ZYXI) is gearing up to announce its quarterly earnings on Tuesday, 2025-11-18. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...